Publication Name	World Journal of Diabetes
Manuscript ID	82046
Country	Indonesia

Received	2022-12-03 15:20
Peer-Review Started	2022-12-03 15:22
To Make the First Decision
Return for Revision	2022-12-26 08:39
Revised	2023-02-02 15:50
Second Decision	2023-04-06 03:27
Accepted by Journal Editor-in-Chief	2023-04-08 14:07
Accepted by Executive Editor-in-Chief	2023-04-11 18:27
Articles in Press	2023-04-11 18:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-05-04 08:34
Publish the Manuscript Online	2023-05-15 15:23

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
Manuscript Source	Invited Manuscript
All Author List	I Dewa Nyoman Wibawa, I Ketut Mariadi, Gde Somayana, Cokorda Istri Yuliandari Krisnawardani Kumbara and Dwijo Anargha Sindhughosa
ORCID	Author(s) ORCID Number I Dewa Nyoman Wibawa http://orcid.org/0000-0001-5190-3072 I Ketut Mariadi http://orcid.org/0000-0001-9665-8082 Gde Somayana http://orcid.org/0000-0002-7099-9222 Cokorda Istri Yuliandari Krisnawardani Kumbara http://orcid.org/0000-0002-3907-2947 Dwijo Anargha Sindhughosa http://orcid.org/0000-0003-4933-9446
Funding Agency and Grant Number
Corresponding Author	I Dewa Nyoman Wibawa, MD, PhD, Professor, Department of Internal Medicine, Gastroentero-hepatology Division, Udayana University, Faculty of Medicine, Jalan PB Sudirman Denpasar, Denpasar 80233, Bali, Indonesia. agusbobwibawa@yahoo.com
Key Words	Fatty liver; Diabetes; Incretin; Insulin resistance
Core Tip	Type 2 diabetes mellitus (T2DM) is correlated with various metabolic disorders, including fatty liver. The influence of T2DM on incretin hormones contributed to fatty liver development. Impairment in lipid and glucose metabolism, fat oxidation, oxidative stress, and other effects lead to liver fat deposition. Therefore, drugs targeting the incretin hormones may provide beneficial effects on patients.
Publish Date	2023-05-15 15:23
Citation	Wibawa IDN, Mariadi IK, Somayana G, Krisnawardani Kumbara CIY, Sindhughosa DA. Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management. World J Diabetes 2023; 14(5): 549-559
URL	https://www.wjgnet.com/1948-9358/full/v14/i5/549.htm
DOI	https://dx.doi.org/10.4239/wjd.v14.i5.549

Full Article (PDF)	WJD-14-549.pdf
Full Article (Word)	WJD-14-549.docx
Manuscript File	82046_Auto_Edited-LM.docx
Answering Reviewers	82046-Answering reviewers.pdf
Audio Core Tip	82046-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	82046-Conflict-of-interest statement.pdf
Copyright License Agreement	82046-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	82046-Language certificate.pdf
Peer-review Report	82046-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	82046-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	82046-Bing-Liu GL-2.png
Scientific Editor Work List	82046-Scientific editor work list.pdf
CrossCheck Report	82046-CrossCheck report.pdf